1. Reddy RG, Gosavi RV, Yadav B et al. AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial. AYU 2020; 41:107-16.
2. Chopra A, Chavan-Gautam P, Tillu G, et al. Co-administration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial. Preprint available at: https://www.medrxiv.org/content/10.1101/2021.06.12.21258345v1
3. Thakar A, Goyal M, Bhinde S, Chhotala Y, Panara K, Chaudhari S. Efficacy of AYUSH-64 as add-on therapy in early stage COVID-19 —An open-label randomized controlled pilot study. 2021. Preprint available at: https://doi.org/10.31219/osf.io/t8wza
4. Singh H, Srivastava S, Yadav B, et al. AYUSH-64 as an adjunct to Standard Care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India. Preprint available at: https://osf.io/xyuas/
5. Singh NR, Madan A, Yadav B, et al. Effect of an Ayurvedic intervention (Ayush-64) in mild to moderate COVID-19: An exploratory prospective single arm clinical trial. Preprint available at: https://osf.io/azb9t/
6. Shamkumar M, Rajput S, Yadav B, et al. Ayurveda formulation AYUSH 64 in asymptomatic and mild COVID 19 infection-A prospective, open label Clinical Study. Preprint available at: https://osf.io/6xa9u/
7. Srivastava A, Rengaraju M, Srivastava S, et al. Efficacy of Two Siddha Polyherbal Decoctions, Nilavembu Kudineer and KabaSura Kudineer, along with Standard Allopathy Treatment in the Management of Mild to Moderate Symptomatic COVID-19 Patients – a Double-Blind, Placebo Controlled, Clinical Trial. Trials. 2021 Aug 28;22(1):570. doi: 10.1186/s13063-021-05478-0.
8. Natarajan S, Anbarasi C, Sathiyarajeswaran P, et al. Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India. Trials. 2021 Sep 15;22(1):623. doi: 10.1186/s13063-021-05583-0. 9. Chopra A, Srikanth N, Patwardhan B; AYUSH CCRAS Research Group. Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis. Complement Ther Med. 2021;62:102768. doi:10.1016/j.ctim.2021.102768
10. A safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19 in high-risk health- care workers: A randomized controlled, non-inferiority trial. Preprint available at: https://osf.io/s3v6k/
11. An Open label prospective interventional study to assess the prophylactic effect of GuduchiGhanVati in COVID-19: A community-based study in a containment zone of Himachal Pradesh, India. doi: 10.31219/osf.io/8vwsy. Preprint available at: https://osf.io/8vwsy
12. GuduchiGhanavati to Improve Immune Status and General Health in the Population at High Risk of COVID-19: Results of An Open-Label Non-Randomized Clinical Trial from India. Preprint available at: https://europepmc.org/article/ppr/ppr296363
13. Godatwar PK, Deshpande S, JoshiDeshmukh PS, et al. Clinical evaluation of Chyawanprash as a preventive measure during the COVID-19 pandemic: An open-label, multicentric, randomized, comparative, prospective, and interventional community-based clinical study on healthy individuals. J Indian Sys Medicine 2021;9:104-13.
14. Jindal N, Rajput S, Yadav B, et al. Chyawanprash as add on to the standard of care in preventing COVID19 infection among apparently healthy health care workers – A single arm, longitudinal study. Ann Ayurvedic Med. 2021; 10(3) 204-219. doi: 10.5455/AAM.73639
15. Rizvi ZA, Tripathy MR, Sharma N, et al. Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19. Front. Pharmacol. 2021 12:746729. doi: 10.3389/fphar.2021.746729
16. Khan F, Ali S, Ganie BA, Rubab I. Immunopotentiating effect of Khamira Marwarid, an herbo-mineral preparation. Methods Find Exp Clin Pharmacol. 2009 Oct; 31(8):513-22. doi: 10.1358/mf.2009.31.8.1419719.
17. Effectiveness of Arsenic Album 30C in prevention of Covid 19 in Individuals residing in Containment Zones of Delhi-A prospective Community Based Cohort Study. Accepted for publication in Journal 'Homeopathy' (Ref No. HOMP-D-21-00070R3)